Molecular Characterization of Human Skin Response to Diphencyprone at Peak and Resolution Phases: Therapeutic Insights-Reference-Cited by-同舟云学术

Molecular Characterization of Human Skin Response to Diphencyprone at Peak and Resolution Phases: Therapeutic Insights

Published:2014-10 Issue:10 Volume:134 Page:2531-2540
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Gulati Nicholas,Suárez-Fariñas Mayte,Fuentes-Duculan Judilyn,Gilleaudeau Patricia,Sullivan-Whalen Mary,Correa da Rosa Joel,Cueto Inna,Mitsui Hiroshi,Krueger James G.

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference25 articles.

1. CXCL10 reduces melanoma proliferation and invasiveness in vitro and in vivo;Antonicelli;Br J Dermatol,2011

2. T-helper-1-cell cytokines drive cancer into senescence;Braumüller;Nature,2013

3. Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy;Bröcker;J Invest Dermatol,1987

4. L-arginine metabolism in myeloid cells controls T-lymphocyte functions;Bronte;Trends Immunol,2003

5. The vast majority of CLA+ T cells are resident in normal skin;Clark;J Immunol,2006

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unique protein signatures evolve during the course of a delayed‐type hypersensitivity reaction in human skin;The Journal of Dermatology;2022-12-28

2. Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases;Allergy;2022-10-08

3. A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low‐level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow‐up based on clinical studies;Journal of Cosmetic Dermatology;2021-10-04

4. Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update;Drug Design, Development and Therapy;2021-03

5. Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation;Journal of the American Academy of Dermatology;2021-02